中证报中证网讯（记者 周璐璐）为推动专业理论与业务实践深度融合，帮助在校学生更好地了解 证券行业前沿动态及实务操作、强化实践能力，促进教学与实践有机融合，近日，西部证券组织风险管 理部业务骨干走进西安财经大学，为金融专业本科生开展风险管理系列课程教学。西安财经大学经济学 院金融系主任、金融学专业负责人周晶主持并点评案例授课，百余名学生聆听课程。 西部证券表示，未来，将持续深化校企资源整合，依托专业人才禀赋，深耕课程共建、课题共研、 实训场景创新，并在党建联建、文化建设交流等维度不断拓展合作边界，推动理论研究与实践教学深度 融合，为资本市场高质量发展提供智力支持与人才保障。 课堂上，西部证券风险管理部业务骨干樊少杰向在场学生系统梳理行业监管机制的发展脉络，解析 证券行业分类评价的制度框架、方法体系、评价标准，以及业务发展状况、风险管理能力、持续合规状 况以及其他专项情况等评价维度，阐释了全面风险管理对券商合规经营与战略转型的支撑作用，提升了 学生对于全面风险管理体系在证券行业应用实践的认知。西部证券风险管理部市场风险与量化团队负责 人徐国澍聚焦证券公司操作风险管控全流程，从定义溯源到类型划分层层递进，结合《证券 ...

Market Overview - The A-share market experienced a decline today, with the Shanghai Composite Index down 0.18%, the Shenzhen Component Index down 0.61%, and the ChiNext Index down 0.68% [1][2]. Sector Performance Consumer Sector - The consumer sector showed strength, particularly in the new consumption direction, with new beverage concepts seeing significant gains. Stocks such as Kweichow Moutai, Junyao Health, and Quanyangquan reached their daily limit [2]. - Within the new beverage concept, subcategories like functional drinks, probiotic drinks, yellow wine, and coconut juice are highlighted. The yellow wine concept performed strongly, with stocks like Jin Feng Jiu Ye, Gu Yue Long Shan, and Qing Fang Cheng experiencing substantial increases [2]. Pharmaceutical Sector - The pharmaceutical sector saw gains in innovative drugs and biological products, with companies like Changshan Pharmaceutical and Sanofi Genzyme experiencing significant stock price increases. Recent catalysts in the innovative drug sector are noted, with a focus on oncology, GLP-1, stem cells, and gene therapy as key areas of interest [4]. Chemical Sector - The chemical sector rallied in the afternoon, particularly in the glyphosate segment, with stocks like Zhongqi Co. and Zhongnong United reaching their daily limit. Other segments such as agricultural chemicals and chemical fibers also saw substantial increases [4]. Investment Insights - Huatai Securities indicates that the yellow wine industry has a rich heritage, with an optimized competitive landscape and upward supply-driven dynamics. The future of the yellow wine industry is expected to see a reconstruction of volume and price logic, with steady upgrades in consumption scenarios and a focus on brand cultivation by leading companies [2]. - Caitong Securities suggests focusing on three main lines in new consumption: emotional resources (pet economy, IP toys, temple economy), emotional resolution (beauty and personal care, gold and jewelry, new food and drink), and reasonable emotional release (outdoor economy, mild intoxication economy, tobacco) [3].

嘉实成长共赢混合型基金招募说明书显示，如果投资者每笔投资持有1年以内，统一收取1.2%的管理 费，持有1年以上则根据每笔投资的真实回报将管理费率分为三档，扣除超额管理费后符合、跑输(业绩 比较基准-3%)、跑赢(业绩比较基准+6%，且收益为正)同期业绩基准分别适用基准档费率1.2%、低档费 率0.6%、升档费率1.5%。 嘉实基金产品总监张之表示，按照推动公募基金高质量发展行动方案中提及的"探索建立与基金业绩表 现挂钩的浮动管理费收取机制"，嘉实成长共赢混合型基金做了相应的约束设置。首先，嘉实成长共赢 混合管理费上浮触发需要满足两个条件：一是显著超越业绩比较基准获得相对收益，二是回报为正赚取 绝对收益。其次，浮动管理费向下和向上的幅度设置非对称，扣除超额管理费之后的年化收益超额6% 以上且绝对收益为正，管理费才能上浮；向下浮动则是跑输业绩比较基准-3%及以上，整体而言向上触 发条件更为严格。 嘉实成长共赢混合型基金的业绩基准为中证800成长指数收益率×70%+恒生指数收益率×10%+中债综合 财富指数收益率×20%。嘉实成长共赢混合拟任基金经理李涛，其能力圈高度契合成长投资方向。李涛 是典型"学研投"背景，毕 ...

Core Viewpoint - Silver Dragon Co., Ltd. is poised for growth in its prestressed materials business, driven by increased demand from key national infrastructure projects and a focus on high-margin products [1][2] Group 1: Production and Capacity - The company has established five major production bases across different regions, with an annual production capacity of 600,000 tons, currently meeting order supply [1] - The addition of Jiangxi Jiujiang Baozelong Prestressed Steel Wire Co., Ltd. enhances the company's regional operational capabilities [1] Group 2: Sales Growth and Market Strategy - In 2024, the company anticipates a 6.62% year-on-year increase in sales volume of prestressed materials, benefiting from the launch of key railway and water conservancy projects [1] - The company is optimizing its product structure, leading to a steady increase in the proportion of high-margin products [1] Group 3: Product Development and Innovation - Key products such as spiral rib prestressed steel wire for track slabs and high-strength prestressed steel strands have achieved significant market breakthroughs, contributing to overall profitability [1] - The company plans to continue supporting national high-speed rail construction and existing line renovations with its core products [2] - Innovations in 2100MPa galvanized steel strands and 2200-2400MPa ultra-high-strength steel strands have improved product performance and expanded their application in the railway market [2] Group 4: Future Outlook - The company aims to maintain a strategy of stabilizing existing markets while expanding into new areas, focusing on enhancing the contribution of high-value-added products in infrastructure projects [2]

与此同时，在社会责任领域，公司同样展现出独特的作为与担当，社会责任实践先后入选"中国民 营企业社会责任优秀案例""企业贡献生物多样性的中国实践""全球契约中国最佳实践案例"。截至2024 年底，奇正藏药连同奇正公司公益基金累计投入1.692亿元用于藏区和西部的医疗、教育、乡村振兴等 社会公益事业。 据悉，全国文明单位是指积极践行社会主义核心价值体系，坚持物质文明建设和精神文明建设两手 抓，各项事业全面协调发展、精神文明建设成效突出，在社会上发挥示范引领作用的单位。 中证报中证网讯（王珞）5月23日，全国精神文明建设表彰大会在北京召开。大会公布第七届全国 文明单位名单，奇正藏药被授予"全国文明单位"称号。 据了解，奇正藏药1995年落户西藏林芝，主营业务为新型藏药的研发、生产和销售，是现代藏药龙 头企业。公司现拥有GMP药厂、GSP营销公司等全资及控股子公司24家，员工3170人，25个独家品种 和141个药品批准文号，产品涵盖骨骼肌肉系统、神经系统、消化系统、心脑血管、呼吸系统、泌尿系 统、妇科、皮肤科、儿科等领域。2024年，公司实现营业收入23.38亿元，同比增长14.32%。 多年来，奇正藏药精准聚焦藏 ...

Group 1 - The first National Investment Conference of Shouxiangu was held in Wuyi County, Zhejiang, focusing on the modernization of traditional Chinese medicine and the development of the health industry [1] - Shouxiangu is the first company in China to independently cultivate a new variety of Ganoderma, named "Xianzhi No. 1," and showcased its full-process quality control system from breeding to production [1] - The company announced a ten-year market expansion plan, utilizing a dual-channel model of "mainly specialty stores + traditional medicine lines," along with eight support measures to assist partners in market expansion [1] Group 2 - During the conference, Shouxiangu signed strategic cooperation agreements with seven partners from the pharmaceutical and health product sectors, indicating strong market potential and brand value [2] - The company aims to enhance its core competitiveness by deepening cooperation with distributors and maintaining its philosophy of "inheriting the thousand-year Ganoderma culture and empowering the health industry with technology" [2] - The chairman of the company expressed a grand vision of establishing a global benchmark for the Ganoderma industry [2]

东城区科协表示，此次活动通过校企联动开辟了科普教育新范式，观典防务技术股份有限公司以其深厚 的技术底蕴为青少年科技素养培育注入了专业力量，充分彰显了企业的社会责任感。 参加此次活动的北京市机关事务管理局幼儿园教师乔源表示，感触颇深，科技应该从娃娃抓起。连昆在 讲座中也谈及自己的小学老师和科技馆老师的科技启蒙令其终身受益。感谢东城区科协与观典防务技术 股份有限公司为大家带来的这场无人机科普盛宴，在今后的教学中将与学生分享无人机相关知识。 此次活动的成功举办，不仅彰显了观典防务在无人机领域的技术领先地位，更体现了高新技术企业参与 社会教育的责任担当。（CIS） 5月23日，由北京市东城区科学技术协会主办、*ST观典承办的"无人机的核心技术和实际应用"科普活 动在崇文科技馆成功举办。作为国家级高新技术企业、国家专精特新"小巨人"企业，公司凭借其专业的 技术实力与丰富的行业经验，为60余名教育工作者打造了一场无人机科技盛宴。 曾荣获中国测绘学会科学技术奖一等奖及二等奖、中国地理信息产业协会地理信息科技进步奖一等奖的 公司项目经理连昆通过"理论+实践"的立体化展示模式，系统解析了现代无人机技术体系及其应用领 域。 连昆 ...

Core Viewpoint - Sunshine Nuohuo has announced a significant asset restructuring plan to acquire 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd, aiming to enhance its capabilities in the pharmaceutical industry through resource integration and strengthen its full-chain layout for sustainable development [1][2]. Group 1: Acquisition Details - The acquisition will be executed through the issuance of shares and convertible bonds, focusing on integrating high-difficulty generic drug and innovative drug research, production, and sales [1]. - Langyan Life is a comprehensive pharmaceutical enterprise with established production capacity and channel resources in high-end chemical drugs and raw materials, covering critical clinical areas such as cardiovascular and anti-infection [1]. Group 2: Strategic Synergy - The collaboration between Sunshine Nuohuo's R&D strengths and Langyan Life's production capabilities is expected to create a synergistic effect, accelerating the technological upgrade of existing production capacity and providing a conversion platform for self-researched pipelines [2]. - Sunshine Nuohuo's innovative drug projects can quickly transition from laboratory to market using Langyan Life's production lines, while Langyan Life's mature products can benefit from Sunshine Nuohuo's R&D resources for process optimization and new indication development [2]. Group 3: Industry Context - The acquisition is positioned as a response to increasing policy changes in the pharmaceutical industry, which have heightened the need for industry chain division and integration [2]. - By pursuing vertical integration, Sunshine Nuohuo aims to enhance cost control across R&D, production, and sales, reducing reliance on external capacity and improving risk resilience amid the normalization of centralized procurement [2]. Group 4: Strategic Upgrade - This acquisition is a key move in Sunshine Nuohuo's strategic upgrade, reinforcing its "CRO + innovative R&D + pharmaceutical industry" layout, maintaining the professionalism of R&D services while enhancing the effectiveness of industrial transformation [3]. - The ongoing integration is expected to become a crucial support for optimizing the company's revenue structure [3].

Group 1: New Energy Business - The company has launched a new business segment focused on new energy and hybrid energy, which includes products and solutions related to energy management and storage systems [1] - Current offerings include Energy Management Systems (EMS), Battery Management Systems (BMS), lithium battery protection boards, and energy storage cabinets [1] - The products can create small-scale power grids that interact flexibly with the public grid while also being relatively independent, enabling multi-energy complementarity with wind, solar, oil, and gas [1] - The company is advancing the research and testing of storage inverters (PCS), with existing customers already trialing the products [1] Group 2: Marine Products - The company's marine products, including generator controllers and engine controllers, are primarily used in various types of vessels for power propulsion and generation control systems [2] - The company has increased investment in marine products and technology, expanding its product line and obtaining certifications from multiple classification societies [2] - The focus is on consolidating existing marine control system business while also targeting higher-end application markets [2]

根据中金公司（601995）数据，一季度公募基金对科创板配置比例明显上升，科创板重仓仓位继续上升 2.4个百分点至15.6%，超配约7个百分点。近日，多家机构分析指出，科技成长的短期调整已较充分， 中长期来看仍是主线，当下或是投资者逢低吸筹的较好时机。 目前，全市场跟踪上证科创板100指数的ETF基金共有11只。其中，广发科创100ETF增强(588680)成立 于2024年6月27日，截至今年5月23日，该基金近6个月回报为9.36%，相较基准指数的超额收益为 5.16%；在产品成立以来的近11个月里，累计回报为38.58%，超越业绩比较基准13.51%。 中证网讯近日，国家数据局综合司印发了《数字中国建设2025年行动方案》，其中提出，深度挖掘人工 智能应用场景，积极开展人工智能高质量数据集建设。着力发展智能网联新能源汽车、人工智能手机和 电脑、智能机器人等新一代智能终端及智能制造装备。 在此背景下，聚焦新兴产业投资的上证科创板100指数与当下的科技发展趋势紧密契合。该指数是从上 交所科创板中选取市值中等且流动性较好的100只证券作为样本，聚焦医药生物、电子、电力设备、计 算机、机械设备等前沿科技领域，五 ...